MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why KMTS Stock surged +2.48% Today — RQD Quant Desk Flash
$30.61 +2.48% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $30.69
Kestra Medical Technologies Ltd. (KMTS) carries a Roarable Rating of D- (Sell) with 43/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • SELL / AVOID
Cap $1.82B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $30.69 (+0.26%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (43/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-6.7% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-6.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for KMTS)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (43/100 Composite)
🔍 WHY KMTS SCORES 43/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (33% of score)
Altman Z-Score 9.65 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9
▲ #2 Bullish Driver: Whale & Options Positioning+10/20 pts (23% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$26.98+1% Next Q
35
Q2 (-2Q)Grade E$27.24+5.6% Next Q
38
Q3 (-1Q)Grade D$28.76+6.4% Next Q
40
CurrentGrade D-$30.61-6.7% Hist 90D α
43
Trajectory: E (35) → D- (43)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a KMTS Turnaround Squeeze
While KMTS currently carries a cautious 43/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($26.69) and Max Pain ($32.14) forces dealer call-delta covering toward $33.68.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $KMTS• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “KMTS Beats Next Quarter EPS Consensus (Jan 28, 2027) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why KMTS Stock surged +2.48% Today — RQD Quant Desk Flash
Kestra Medical Technologies Ltd. (KMTS) surged +2.48% to $30.61, trading at 97% of its 52-week range ($17.34 – $31.06). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 97% of its 52-week range ($17.34 – $31.06) with RSI-14 at 57.5 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $30.61 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 51.4% gross margin and $0 annual free cash flow.
Live KMTS Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring KMTS)
- ✓Walkthrough of KMTS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
KMTS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +47.73%▲ RESISTANCE BREAKOUT
2026-10-30O $30.73H $31.06L $28.77C $30.61VOL 324.9K
RES: $30.20SUP: $23.27SMA50: $26.69SMA200: $23.81
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
KMTS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +59.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on KMTS today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for KMTS. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for KMTS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (KMTS)
Health Care Rank #541 of 1016
⚔️ ATEC vs KMTS Full Matrix →
1. Head-to-Head Health Care Peer Comparison (KMTS vs. ATEC, XRAY, LMAT, INSP)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Kestra Medical Technologies Ltd. (KMTS) ranks #541 by composite RQD confidence (43/100, grade D-) and #278 by equity capitalization ($1.82B). Within this direct 5-issuer industry benchmark cohort, INSP leads on earnings valuation at 14.2x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. LMAT currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with KMTS at 43/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| KMTS
ACTIVE
Kestra Medical Technologies Ltd. | D- | 43/100 | — | 51.4% | -35.0% | +2.48% | $1.82B | Benchmark Subject |
| ATEC Alphatec Holdings Inc. | D- | 38/100 | — | 69.6% | -18.4% | -0.70% | $1.76B | /atec-vs-kmts → |
| XRAY DENTSPLY SIRONA Inc. | D | 46/100 | — | 50.0% | -11.0% | +1.80% | $1.92B | /xray-vs-kmts → |
| LMAT LeMaitre Vascular Inc. | B | 74/100 | 33.8x | 71.5% | 14.7% | +2.90% | $1.95B | /lmat-vs-kmts → |
| INSP Inspire Medical Systems Inc. | C- | 61/100 | 14.2x | 85.4% | 6.0% | +0.30% | $2.06B | /insp-vs-kmts → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-04-30 • CIK 0001877184In its most recent audited fiscal period (FY2025, filed 2026-04-30), Kestra Medical Technologies Ltd. (KMTS) reported GAAP revenue of $95.1M (+59.0% vs. FY2024 revenue of $59.8M , and +242.0% cumulative change since FY2023) , GAAP net income of -$131.6M, operating cash flow of -$81.7M, and free cash flow of -$116.6M (-16.0% YoY). On the balance sheet, KMTS closed FY2025 with $379.3M in total assets against $42.3M in total debt (Altman Z-Score: 9.65, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-04-30 | $95.1M | -$131.6M | -$81.7M | -$116.6M | $379.3M | $42.3M |
| FY2024 (FY) | 2025-04-30 | $59.8M | -$113.8M | -$77.6M | -$100.5M | — | — |
| FY2023 (FY) | 2024-04-30 | $27.8M | -$94.1M | -$72.2M | -$72.2M | — | — |
3. KMTS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs KMTS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Kestra Medical Technologies Ltd. (NASDAQ: KMTS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $30.61 (+2.48% 1D, market cap $1.82B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, KMTS ranks #541 in composite RQD confidence.
How does KMTS compare to ATEC and XRAY in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), KMTS carries a Roarable D- (43/100 RQD), trailing P/E of N/A, gross margin of 51.4%, and ROIC of -35.0%. By comparison, ATEC (Alphatec Holdings Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -18.4%, cap $1.76B) and XRAY (DENTSPLY SIRONA Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, INSP leads on earnings multiple (14.2x) while LMAT leads on capital efficiency (14.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for KMTS?
Per KMTS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-04-30, CIK 0001877184), Kestra Medical Technologies Ltd. generated $95.1M in revenue (+59.0% YoY), -$131.6M in net income, and -$116.6M in free cash flow against $379.3M in total assets and $42.3M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is KMTS trading relative to its 50-day, 200-day, and 52-week technical levels?
KMTS last traded at $30.61 (+2.48% on volume of 470,684 shares), positioning the stock +14.69% above its 50-day simple moving average ($26.69) and +28.56% above its 200-day simple moving average ($23.81). Across its 52-week range of $17.34 to $31.06, KMTS sits at the 96.7% percentile with a 14-day RSI of 57.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($26.78 to $34.44).
KMTS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is KMTS stock moving today?
Why KMTS Stock surged +2.48% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.